Obesity Reviews

New series on appetite peptides and hormones, and on diagnostics in obesity
pp. 269-269(1)

Prevalence of obesity in Taiwan
pp. 271-274(4)
Author: Chu, N.-F.

Obesity and the electrocardiogram
pp. 275-281(7)
Authors: Fraley, M. A.; Birchem, J. A.; Senkottaiyan, N.; Alpert, M. A.

Diagnosis and management of the metabolic syndrome in obesity
pp. 283-296(14)
Authors: Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.

Role of cholecystokinin in appetite control and body weight regulation
pp. 297-306(10)
Authors: Little, T. J.; Horowitz, M.; Feinle-Bisset, C.

PYY3-36 as an anti-obesity drug target
pp. 307-322(16)
Authors: Boggiano, M. M.; Chandler, P. C.; Oswald, K. D.; Rodgers, R. J.; Blundell, J. E.; Ishii, Y.; Beattie, A. H.; Holch, P.; Allison, D. B.; Schindler, M.; Arndt, K.; Rudolf, K.; Mark, M.; Schoelch, C.; Joost, H. G.; Klaus, S.; Thöne-Reineke, C.; Benoit, S. C.; Seeley, R. J.; Beck-Sickinger, A. G.; Koglin, N.; Raun, K.; Madsen, K.; Wulff, B. S.; Stidsen, C. E.; Birringer, M.; Kreuzer, O. J.; Deng, X. Y.; Whitcomb, D. C.; Halem, H.; Taylor, J.; Dong, J.; Datta, R.; Culler, M.; Ortmann, S.; Castañeda, T. R.; Tschöp, M.

Orlistat for the treatment of obesity: cost utility model
pp. 323-328(6)
Author: Foxcroft, D. R.

Hippocrates: ‘To talk, move during conversation, think and listen to others increases the combustion’
pp. 329-329(1)

Author index
pp. 331-333(3)

Subject index
pp. 333-334(2)

Editorial acknowledgements
pp. 335-335(1)